Delivery Order SPE2DB22D2206-SPE2DB25FFW97

Award Date 2/28/25
Potential Completion Date 3/21/25
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of GAMUNEX-C 10 gram/100 ml vials. The $3,606.84 firm-fixed-price delivery order has a completion date of November 20, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,109.55 firm fixed-price delivery order contract is for the supply of GAMUNEX-C 10 gram/100 ml vials, a specialty medication, with a completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,123.20 Firm Fixed Price delivery order is for the supply of GAMUNEX-C 5 gram/50 mL vials, a specialty pharmaceutical product, with a completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,925.84 firm fixed-price delivery order is for the supply of GAMUNEX-C 40 gram/400 ml vials, with an ultimate completion date of January 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,438.20 firm fixed-price delivery order covers the supply of GAMUNEX-C 10 gram/100 ml vials, a specialty medication, with a performance period through December 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $3,731.46 firm fixed-price delivery order is for the supply of GAMUNEX-C 10 gram/100 mL vials, with a completion date of December 16, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,325.64 firm fixed-price delivery order is for the supply of GAMUNEX-C 10 gram/100 ml vials and has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,123.20 firm fixed-price delivery order is for GAMUNEX-C 5 gram/50 ml vials, a specialty immunoglobulin medication. The award has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,634.72 firm-fixed-price delivery order is for the supply of GAMUNEX-C 20 gram/200 ml vials, a specialty pharmaceutical product, with an ultimate completion date of August 26, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,147.50 firm-fixed-price delivery order is for the supply of GAMUNEX-C 20 gram/200 ml vials, with a completion date of October 18, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFW97
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,104.70 firm fixed-price delivery order is for the supply of GAMUNEX-C 10 gram/100 ml vials, with an ultimate completion date of March 21, 2025.

The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing critical medical commodities across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, will be responsible for delivering the requested medical products to support the healthcare needs of military personnel, veterans, and other federal beneficiaries through the DLA's medical supply chain.

Generated 5/30/25, 10:09 AM